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Abstract 
The prolonged residence of drug formulation in the nasal cavity is of utmost importance for intranasal drug 
delivery. The objective of the present investigation was to develop a mucoadhesive in situ gel with reduced 
nasal mucocilliary clearance in order to improve the bioavailability of the antiemetic drug, Metoclopramide 
Hydrochloride. The in situ gelation upon contact with nasal mucosa was conferred via the use of the 
thermogelling Methyl cellulose whereas mucoadhesion and drug release enhancement were modulated via the 
use of sodium alginate and polyethylene glycol polymers respectively. The results revealed that the 
mucoadhesive polymer increased the gel viscosity but reduced its sol gel transition temperatures and the drug 
release. The inclusion of polyethylene glycol polymer counteracted the effect of mucoadhesive polymer where 
by it decreased the gel consistency and increased the sol gel transition as well as in vitro drug diffusion. The in 
vitro tests performed for mucoadhesive strength and drug diffusion showed that nasal in situ gelling 
formulations prepared are having good mucoadhesive strength with nearly100% drug diffusion within four 
hours. So this study points to the potential of mucoadhesive in situ nasal gel in terms of ease of administration, 
accuracy of dosing, prolonged nasal residence and improved nasal bioavailability.  
Keywords: Nasal Gel, Metoclopramide Hydrochloride, Methyl Cellulose, Mucocilliary Clearance. 
1. Introduction 
Metoclopramide Hydrochloride (MET HCl) is a 
potent antiemetic, effective in the treatment of nausea 
and vomiting associated with cancer therapy, 
pregnancy, migraine, etc. Oral bioavailability of 
Metoclopramide Hydrochloride is highly variable, 
showing values between 32–98% due to extensive 
pre-systemic metabolism.1 Oral forms of 
Metoclopramide Hydrochloride often get vomited out 
before systemic absorption. Parenteral or rectal 
administration results in low patient compliance. In 
this regard, the intranasal delivery seems to be an 
attractive alternative. The major disadvantage 
associated with nasal drug delivery is rapid 
mucocilliary clearance (MCC) that limits the time 
available for drug absorption from applied dosage 
form. (2) The half-life of clearance for both liquid and 
powder formulation that are not mucoadhesive is in 
the order of 15–20 min. (3) Therefore, a plausible 
strategy is to decrease MCC by the use of 
gel/mucoadhesive formulations to prolong the 
residence time at the nasal absorption site and 
thereby facilitate the uptake of drug. Ordinary gels 
are difficult to administer and an accurate drug dose 
cannot be measured. Mucoadhesive powders are not 
highly favoured products. They can cause irritation 
on the nasal mucosa and give a gritty feel to the 
tissue, besides the difficulty and the cost of 
manufacturing powders with specified morphology. 
A nasal mucoadhesive in situ gel appears very 
attractive since it is fluid like prior to nasal 
administration and thus can be easily be instilled as a 
drop, allowing accurate drug dosing.  
Methyl Cellulose can markedly prolong the residence 
time of drugs in the nasal cavity due to their desirable 
mucoadhesive property. (4) Additionally, due to their 
high viscosity following hydration in the nasal cavity, 
methyl cellulose can sustain the release of drugs. For 
these reasons, using methyl cellulose as absorption 
enhancer can lead to improved intranasal absorption 
and increased bioavailability.5 The aim of the present 
study is to develop a Metoclopramide Hydrochloride, 
mucoadhesive nasal in situ gel using Methyl 
Cellulose polymer. The optimized nasal in situ gel 
with favourable gelation, rheological behaviour, 
release and mucosal permeation ability was selected 
for further bioavailability study. 
2. Materials and Methods 
2.1 Materials 
Metoclopramide Hydrochloride was a kind gift from 
Aldoc Pharmaceutical (Kota, India), Sodium alginate 
(Na alginate), and polyethylene glycol 6000 (PEG 
6000) were collected from Kota College of 
Pharmacy, Kota. 
2.2 Method 
2.2.1 Preparation of mucoadhesive thermo 
reversible nasal gels: 
Metoclopramide Hydrochloride along with 
mucoadhesive polymer, and /or PEG 6000 and 
methyl paraben was dissolved in double distilled 
water by agitation at room temperature. After cooling 
the solution to 40C, Methyl Cellulose was added 
slowly with agitation. The resulting dispersion was 
then kept overnight at 40C until clear and viscous 
transparent solution was formed. Finally volume was 
adjusted by using cold distilled water. 
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Evaluation of final formulations was done with 
respect to clarity, pH, content uniformity, gelation 
temperature, mucoadhesive force, diffusion through 
nasal mucosa and viscosity of formulation.
 
Table I: Composition of various thermoreversible mucoadhesive nasal gel formulations 
Composition F1 F2 F3 F4 
Metoclopramide HCl 10 10 10 10 
Methyl cellulose 18 18 18 18 
Na-Alginate ... 0.2 0.2 ... 
PEG 6000 ... ... 0.4 0.4 
Methyl Parabens 0.33 0.33 0.33 0.33 
Purified Water q.s q.s q.s q.s 
*All concentrations in percentage; batch size 20ml 
2.3 Evaluation of formulation 
2.3.1. Clarity: 
The clarity of various formulations was determined 
by visual inspection under black and white 
background and it was graded as follows; turbid: +, 
clear ++, very clear (glassy): +++. 
2.3.2. pH of Formulation: 
1ml quantity of each formulation was transferred to 
the 10ml volumetric flask and diluted by using 
distilled water to make 10ml. pH of resulting solution 
was determined by using pH meter.  
(Systronics ì pH System 362) 
2.3.3. Content Uniformity: 
1ml of formulation was taken in 100ml volumetric 
flask, added 50ml of distilled water with gentle 
shaking and final volume was adjusted to 100ml. 1ml 
quantity from this solution was transferred into the 
100ml volumetric flask and final volume was made 
to 100ml by using distilled water to get 10mg/ml. 
Finally the absorbance of prepared solution was 
measured at 212 nm by using UV visible 
spectrophotometer. (Shimadzu UV 1800, Japan) 
2.3.4. Gelation Temperature: 
The gelation temperature of aqueous solution of 
Methyl Cellulose was measured by using procedures 
reported by Choi et al (6). In brief, 10ml volume of 
solution was transferred to 20ml transparent vial 
containing a magnetic stirrer bar (1x5/16 inch 
octagonal). The vial was heated at an increasing rate 
of 10°C/min with constant stirring at 100 rpm. The 
temperature at which rotation of bar stopped was 
taken as the gelation temperature. 
3. Result 
3.1 Clarity, pH and Content Uniformity: 
All the prepared sets of formulations were found to 
be clear. pH of all the formulations was found to be 
in the range of 4.9-6.3. The percentage drug content 
of all prepared nasal formulations were checked and 
found to be in the range of 70-103%. The percentage 
drug content of formulations from same batch was 
found to be uniform. 
 
Table II: Clarity, pH and content uniformity of mucoadhesive nasal insitu gelling formulations 
Formulation Clarity pH Content Uniformity n = 3 
F1 +++ 6.3 103.88 
F2 ++ 5.8 96.34
F3 +++ 5.2 81.04
F4 +++ 4.9 70.03 
3.2 Gelation Temperature: 
Various excipients like mucoadhesive polymer as 
well as PEG 6000 had shown to have effect on the 
gelation temperature. Mucoadhesive polymer reduced 
the gelation temperature while PEG 6000 increased 
the Tsol-gel of the corresponding mucoadhesive nasal 
insitu gelling formulations in a concentration 
dependent manner as described earlier. 
 
Table III: Gelation temperature of mucoadhesive nasal insitu gelling formulations 
Formulation Gelation Temperature(0C) 
Mean ± S.D. n=3 
F1 28.88±0.13 
F2 27.32±0.39 
F3 30.03±0.19
F4 30.92±0.27 
 
4. Discussion 
                The physiological range of the nasal 
mucosal temperature lies between 32-340 C. (7) So the 
thermoreversible nasal gels were prepared with the 
phase transition temperature in the range of 27-300C. 
From viscosity studies all formulations are in a liquid 
state at room temperature for ease of administration 
and accurate measurement of dose and would be 
converted into gel with increased residence time at 
the lower limit of the nasal physiological temperature 
range. The loading of Metoclopramide Hydrochloride 
in the different formulations was kept at 10%w/v 
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such that 100ìl gel (the optimum volume for nasal 
administration) would contain 10mg, which is the 
adult dose. (8) 
                Lysozyme is formed in the nasal secretions, 
which is responsible for destroying certain microbes 
at acidic pH. Under alkaline pH lysozyme is inactive 
and nasal tissue is susceptible to microbial infection. 
It is therefore advisable to keep the pH of formulation 
in the range of 4.5-6.5. (9) 
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Fig- Formulations of Metoclopramide Hydrochloride nasal gel. 
 
